IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by IRADIMED CORPORATION on October 30, 2017. The report serves to announce the Company's financial results for the third quarter ended September 30, 2017. The Company is incorporated in Delaware and identifies as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the body text. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that Section. No specific guidance, outlook, or risk factors are detailed in the provided text.
Key Facts for Investor Verification
- Verify the specific revenue and net income figures for the third quarter ended September 30, 2017, by reviewing Exhibit 99.1 (Press Release).
- Confirm year-over-year growth rates and margin trends from the attached press release.
- Review the press release for any updated forward-looking guidance or management commentary not present in this summary.
- Note the Company's status as an emerging growth company and its election not to use the extended transition period for new accounting standards.